A Review of Drospirenone for Safety and Tolerability and Effects on Endometrial Safety and Lipid Parameters Contrasted with Medroxyprogesterone Acetate, Levonorgestrel, and Micronized Progesterone-Reference-Cited by-同舟云学术

A Review of Drospirenone for Safety and Tolerability and Effects on Endometrial Safety and Lipid Parameters Contrasted with Medroxyprogesterone Acetate, Levonorgestrel, and Micronized Progesterone

Published:2006-06 Issue:5 Volume:15 Page:584-590
ISSN:1540-9996
Container-title:Journal of Women's Health
language:en
Short-container-title:Journal of Women's Health

Author:

Shulman Lee P.¹

Affiliation:

1. Department of Obstetrics and Gynecology, Division of Reproductive Genetics and Graduate Program in Genetic Counseling, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Publisher

Mary Ann Liebert Inc

Subject

General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jwh.2006.15.584

Reference51 articles.

1. Oral medroxyprogesterone in the treatment of postmenopausal symptoms

2. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss

3. Factors Associated with Withdrawal Bleeding after Administration of Oral Dydrogesterone or Medroxyprogesterone Acetate in Women with Secondary Amenorrhea

4. Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea**Sponsored in part by a grant from La Salle Laboratories, Washington, D.C.††Presented in part at the 46th Annual Meeting of The American Fertility Society, Washington, D.C., October 15 to 18, 1990.

5. New Progestogens

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of continuous-combined oral drospirenone- estradiol on blood pressure, body weight & lipid profile in early menopausal women;Indian Journal of Medical Research;2021

2. Drospirenone: a Latin American perspective for oestrogen-free oral contraception;The European Journal of Contraception & Reproductive Health Care;2020-11-06

3. Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone;Journal of Basic and Clinical Physiology and Pharmacology;2019-08-30

4. Menopausa e síndrome metabólica;Arquivos Brasileiros de Endocrinologia & Metabologia;2014-03

5. Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome;AGE;2013-07-07